HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical studies.

Abstract
Neuropeptide Y (NPY), a 36-amino acid peptide, is present in some hippocampal interneurons and nerve terminals and seems to modulate glutamatergic transmission in this structure. Earlier studies of some other authors showed an increase in NPY expression in the hippocampus during seizures and activation of ionotropic glutamate receptors. In the present study the effect of metabotropic glutamate receptor (mGluR) stimulation was investigated in rat hippocampus by immunohistochemical methods. It was found that (1S,3R)1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD), a selective agonist of mGluRs injected into the rat lateral ventricle (1 mumol/10 microliters) or hippocampus (0.1 mumol/1 microliter), 24 h before taking the brains for immunohistochemical studies, induced a significant increase in NPY-immunoreactivity in the hippocampus, especially in the hilar region. The obtained results indicate that mGluRs positively modulate the NPY content in the hippocampal neurons.
AuthorsM Smiałowska, M Bajkowska
JournalPolish journal of pharmacology (Pol J Pharmacol) 1997 Sep-Oct Vol. 49 Issue 5 Pg. 357-62 ISSN: 1230-6002 [Print] Poland
PMID9566036 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Excitatory Amino Acid Agonists
  • Neuropeptide Y
  • Receptors, Metabotropic Glutamate
  • Cycloleucine
  • 1-amino-1,3-dicarboxycyclopentane
Topics
  • Animals
  • Cycloleucine (administration & dosage, analogs & derivatives, pharmacology)
  • Excitatory Amino Acid Agonists (administration & dosage, pharmacology)
  • Hippocampus (drug effects, metabolism)
  • Immunoenzyme Techniques
  • In Vitro Techniques
  • Injections, Intraventricular
  • Male
  • Microinjections
  • Neuropeptide Y (biosynthesis)
  • Rats
  • Rats, Wistar
  • Receptors, Metabotropic Glutamate (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: